About Mary Beth Kreissler
Form D filings for Candesant Biomedical from 2020 to 2023 list Mary Beth Kreissler as executive officer.
Mary Beth Kreissler first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Mary Beth Kreissler in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Mary Beth Kreissler works with at each company, as listed on that company's latest Form D.
Candesant Biomedical, Inc. · Form D, Jun 6, 2023
KL
Karen Long
Director
BH
Brad Hauser
Director
NH
Niquette Hunt
President and Chief Executive Officer, director
SB
Samara Braunstein
Director
MK
Michael Kane
Director
EM
Eileen McGuire
Director